Author

Alicia N. Pepper

Observed names: A.N. Pepper, Alicia N Pepper, Alicia Nicole Pepper, Pepper, Alicia N.

Observed institutions: EVERSANA (Canada), Wilfrid Laurier University, McMaster University

OpenAlex ID: A5014379360

Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany

2020 · Matthias Augustin, Daniel Wirth, et al. · Journal of Dermatological Treatment · 15

The Pea Nodulation Mutant R50 (sym16) Displays Altered Activity and Expression Profiles for Cytokinin Dehydrogenase

2008 · Mark Held, Alicia N. Pepper, et al. · Journal of Plant Growth Regulation · 12

Menin Links the Stress Response to Genome Stability in Drosophila melanogaster

2010 · Maria Papaconstantinou, Alicia N. Pepper, et al. · PLoS ONE · 11

Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective

2022 · Adrian Kilcoyne, Edward Jordan, et al. · Journal of Medical Economics · 7

Menin: The Protein Behind the MEN1 Syndrome

2009 · Maria Papaconstantinou, Bart M. Maslikowski, et al. · Advances in experimental medicine and biology · 5

Psy12 Cost Per Responder Analysis of Guselkumab Versus Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis Based on the Eclipse Trial

2019 · C. Druchok, A.N. Pepper, et al. · Value in Health · 1

Adjusted Comparison of First-line Enfortumab Vedotin Plus Pembrolizumab Versus Platinum-based Chemotherapy ± Avelumab Maintenance for the Treatment of Locally Advanced/Metastatic Urothelial Carcinoma

2026 · Ryan Dillon, Robert Jones, et al. · European Urology Oncology

P.113 Heterogeneity in treatment outcomes for systemic sclerosis with or without interstitial lung disease: a systematic literature review

2026 · Emily Glowienka, Ian Steinfield, et al. · Poster presentations

Evaluating the cost per month of response for olutasidenib (OLU) versus ivosidenib (IVO) for patients with relapsed/refractory (R/R) mutant IDH1 (m IDH1 ) acute myeloid leukemia (AML).

2026 · Yasmin Abaza, Rory Shallis, et al. · Journal of Clinical Oncology

HTA97 Cost-Effectiveness Modeling Challenges and Trends in the Neoadjuvant and Perioperative Settings: A Review of NICE Oncology Submissions

2025 · Chloi Theriou, Eleni Pavlidou, et al. · Value in Health

HTA27 How Have Canada's Drug Agency Guidelines Impacted Choice of Model Structure and Use of Partitioned Survival Models in Oncology Submissions?

2025 · Chloi Theriou, Eesha Kodi, et al. · Value in Health

The relationship between forced vital capacity (FVC), modified Rodnan skin score (mRSS) and long-term patient outcomes in systemic sclerosis (SSc) with interstitial lung disease (ILD): a literature review

2024 · Ciara O'Shea, Emily Glowienka, et al. · European Respiratory Journal

Characterization of Drosophila Menin Protein Interactions and a Potential Role for Menin in the Insulin Signalling Pathway

2013 · Pepper, Alicia N. · MacSphere (McMaster University)

Menin: Protein Behind the MEN! Syndrome

2009 · Maria Papaconstantinou, Bart M. Maślikowski, et al.

Works count: 16

Citation count: 51

H-index: 5

I10-index: 3